Impact of monoclonal antibody treatment on hospitalization and mortality among non-hospitalized adults with SARS-CoV-2 infection

J. Ryan Bariola, Erin K. McCreary, Richard J. Wadas, Kevin E. Kip, Oscar C. Marroquin, Tami Minnier, Stephen Koscumb, Kevin Collins, Mark Schmidhofer, Judith A. Shovel, Mary Kay Wisniewski, Colleen Sullivan, Donald M. Yealy, David A Nace, David T. Huang, Ghady Haidar, Tina Khadem, Kelsey Linstrum, Christopher W. Seymour, Stephanie K. Montgomery, Derek C. Angus, Graham M. Snyder
doi: https://doi.org/10.1101/2021.03.25.21254322
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
Posted March 30, 2021.
Download PDF
Data/Code
Email
Impact of monoclonal antibody treatment on hospitalization and mortality among non-hospitalized adults with SARS-CoV-2 infection
J. Ryan Bariola, Erin K. McCreary, Richard J. Wadas, Kevin E. Kip, Oscar C. Marroquin, Tami Minnier, Stephen Koscumb, Kevin Collins, Mark Schmidhofer, Judith A. Shovel, Mary Kay Wisniewski, Colleen Sullivan, Donald M. Yealy, David A Nace, David T. Huang, Ghady Haidar, Tina Khadem, Kelsey Linstrum, Christopher W. Seymour, Stephanie K. Montgomery, Derek C. Angus, Graham M. Snyder
medRxiv 2021.03.25.21254322; doi: https://doi.org/10.1101/2021.03.25.21254322
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area